Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 November 2024 | Story Anthony Mthembu | Photo Tania Allan
Business School 25 Year Celebration
Some of the guests and staff members of the UFS Business School who attended the 25th anniversary celebration of the school.

To commemorate its 25th anniversary, the Business School at the University of the Free State (UFS) held a celebratory event on the UFS Bloemfontein Campus on 22 November 2024.

Prof Frans Prinsloo, acting Dean of the Faculty of Economic and Management Sciences (EMS) at the UFS who attended the event, said, “The occasion is not just a celebration of the passing of time, but it’s also an opportunity for us to reflect on the values, achievements, and aspirations that have shaped the journey of the UFS Business School.” The event, which was regarded as a ‘momentous milestone’, was also attended by Prof Nicolene Barkhuizen, Director of the UFS Business School, Prof Frederick Fourie and Prof Bennie Anderson – founding members of the Business School, as well as Prof Tienie Crous and Prof Hendri Kroukamp, who are former deans of EMS.

A walk down memory lane

In his opening address, Prof Prinsloo reflected on the growth of the Business School over the past 25 years and highlighted some of the achievements of the staff that make up the Business School. However, the highlight of the event for many in the audience was the trip down memory lane by the founding members of the Business School as well as the former deans of the faculty.

 In their address, Profs Fourie and Anderson shared some of their fondest memories and experiences as they worked towards putting together the Business School. For instance, Prof Fourie indicated that in order to ensure that the syllabus was of high quality, the founding members had to travel overseas and learn from several institutions, such as Harvard Business School.

In addition, Profs Fourie and Anderson spoke extensively about their pride in the Business Management and Leadership (BML) programme, offered by the Business School. According to Prof Fourie, the degree was the brainchild of Prof Anderson, who for several reasons wanted to consider working adults who might not have had experience in school learning. As such, they consider the BML programme as one of their most special achievements, given its impact. Furthermore, Prof Crous and Prof Kroukamp also shared their memories of being part of the institution, and specifically the Business School.

Forging ahead for another 25 years

In the pursuit of 25 more years, Prof Barkhuizen indicated that the school is aiming to achieve success with several projects. These include staff and student exchanges in order to optimise the experience of both stakeholders. “Even though we have a global reach, it is important for us to apply it locally,” she said. In addition, Prof Barkhuizen highlights that for the Business School to continue serving the needs of its unique student clientele, it needs to become more agile. As such, it will continuously reinvent its programmes with the input of its stakeholders. For instance, she indicated that the school is looking at implementing joint qualification offerings, among other things.

As the event ended, Prof Barkhuizen said that she was, “so proud of the progress made by the Business School; it has been a journey to get here, but this function today taught me to never give up hope and not to give up on one’s dreams”.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept